Principal Investigator
Benjamin Diamond
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20230227
Clinical Trial Summary
Phase 2, Single-Arm Study of Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients with Relapsed/Refractory Multiple Myeloma
Phase
Phase II
Funding Agency/Sponsor
Institutional
Disease
Myeloma
Contact Information
Phone Number
305-243-2647